Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Article in Journal of Medical Economics (June 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Journal of Medical Economics (June 2024)
Article in Blood Advances (November 2023)
Article in Haematologica (September 2023)